| Paradoxical absence of a prothrombotic phenotype in a mouse model of severe hyperhomocysteinemia. | |
| | |
MedLine Citation:
|
PMID: 22186991 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Hyperhomocysteinemia confers a high risk for thrombotic vascular events, but homocysteine-lowering therapies have been ineffective in reducing the incidence of secondary vascular outcomes, raising questions regarding the role of homocysteine as a mediator of cardiovascular disease. Therefore, to determine the contribution of elevated homocysteine to thrombosis susceptibility, we studied Cbs(-/-) mice conditionally expressing a zinc-inducible mutated human CBS (I278T) transgene. Tg-I278T Cbs(-/-) mice exhibited severe hyperhomocysteinemia and endothelial dysfunction in cerebral arterioles. Surprisingly, however, these mice did not display increased susceptibility to arterial or venous thrombosis as measured by photochemical injury in the carotid artery, chemical injury in the carotid artery or mesenteric arterioles, or ligation of the inferior vena cava. A survey of hemostatic and hemodynamic parameters revealed no detectible differences between control and Tg-I278T Cbs(-/-) mice. Our data demonstrate that severe elevation in homocysteine leads to the development of vascular endothelial dysfunction but is not sufficient to promote thrombosis. These findings may provide insights into the failure of homocysteine-lowering trials in secondary prevention from thrombotic vascular events. |
| | |
Authors:
|
Sanjana Dayal; Anil K Chauhan; Melissa Jensen; Lorie Leo; Cynthia M Lynch; Frank M Faraci; Warren D Kruger; Steven R Lentz |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't Date: 2011-12-20 |
Journal Detail:
|
Title: Blood Volume: 119 ISSN: 1528-0020 ISO Abbreviation: Blood Publication Date: 2012 Mar |
Date Detail:
|
Created Date: 2012-03-30 Completed Date: 2012-05-25 Revised Date: 2013-05-22 |
Medline Journal Info:
|
Nlm Unique ID: 7603509 Medline TA: Blood Country: United States |
Other Details:
|
Languages: eng Pagination: 3176-83 Citation Subset: AIM; IM |
Affiliation:
|
Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA. sanjana-dayal@uiowa.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Cystathionine beta-Synthase / genetics Disease Models, Animal* Female Hematologic Tests Hemodynamics / genetics, physiology Humans Hyperhomocysteinemia / blood, complications*, genetics, pathology* Male Mice* Mice, Inbred C57BL Mice, Knockout Phenotype Risk Factors Severity of Illness Index Thrombosis / etiology* |
| Grant Support | |
ID/Acronym/Agency:
|
HL062984/HL/NHLBI NIH HHS; HL063943/HL/NHLBI NIH HHS; NS024621/NS/NINDS NIH HHS |
| Chemical | |
Reg. No./Substance:
|
EC 4.2.1.22/Cystathionine beta-Synthase |
| Comments/Corrections | |
Comment In:
|
Blood. 2012 Mar 29;119(13):2977-8
[PMID:
22461473
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Serotonin 5-HT2B receptors are required for bone-marrow contribution to pulmonary arterial hypertens...
Next Document: Therapeutic applications of macrophage colony-stimulating factor (CSF-1) and antagonists of CSF-1 re...